Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Vaccine for brain cancer shows promise

June 3, 2010 Research and Development Cancer, GBM, ImmunoCellular

Early stage trials of a new treatment for the brain cancer glioblastoma multiforme have shown promise. ICT-107 is being developed …
News

Chiltern Announces Early Phase Partnership with Tayside Academic Health Sciences Centre

June 3, 2010 Research and Development

Chiltern will draw upon many parts of TAHSC, including the Clinical Research Centre (CRC) which is located on the same …
News
Press release

Contract research news in brief

June 1, 2010 Research and Development CRO, NIB

Irish contract research organisation ICON plc has acquired Timaq Medical Imaging, a Swiss provider of imaging services to pharmaceutical and …
News

Inspra performs strongly in heart failure patients

May 28, 2010 Research and Development, Sales and Marketing Inspra, Pfizer, chronic heart failure, heart failure

Pfizer is to end a clinical trial of Inspra early because of signs that it significantly cuts the risk of …
News

Pfizer R&D head exits for AstraZeneca

May 27, 2010 Research and Development AstraZeneca, Pfizer, appointment, research and development

One of Pfizer’s two heads of research and development Martin Mackay is to leave the company for rivals AstraZeneca. Only …
News

Sanofi signs biomedical collaboration with MIT

May 27, 2010 Research and Development MIT, Sanofi-Aventis, academia, biomedical

Sanofi-Aventis has formed a strategic alliance with the Centre for Biodmedical Innovation  at the Massachusetts Institute of Technology. The alliance, …
News

Roche forms translational medicine research hub

May 26, 2010 Research and Development Roche, Switzerland, academic research, translational

Roche is linking up with Basel’s university and university hospital in a ‘strategic alliance’ that will establish and manage what …
News
Abbott sign

Abbott starts head-to-head MS trial

May 25, 2010 Research and Development, Sales and Marketing Abbott, Avonex, Biogen, Gilena, daclizumab

Abbott has started enrolment for a phase III trial of daclizumab, a once-monthly injection for relapsing-remitting multiple sclerosis that it …
News

Kaiser Permanente unit joins Quintiles ‘Prime Site’ network

May 25, 2010 Research and Development CRO, Kaiser Permanente, Quintiles

A unit of US health maintenance organisation Kaiser Permanente has become the fourth in Quintiles’ network of ‘Prime Sites’ – …
News

Lucentis boosted by diabetic vision study

May 24, 2010 Research and Development, Sales and Marketing AMD, DME, Lucentis, Novartis

A phase III trial of Novartis’ ranibizumab has shown it to be superior at promoting vision gain in patients with …
News

Boehringer selects lead candidate for Alzheimer’s

May 24, 2010 Research and Development Ablynx, Boehringer

Boehringer Ingelheim has selected a lead candidate for further development to treat Alzheimer’s disease from its collaboration with Ablynx. Belgium-based …
News

Eisai opens $100m parenterals plant in North Carolina

May 24, 2010 Manufacturing and Production, Research and Development Aricept, Eisai, eribulin, parenterals

Japanese drugmaker Eisai has opened a 65,000-sq.ft. facility at Research Triangle Park in North Carolina, USA, which will serve as …
News

First artificial life created

May 24, 2010 Research and Development Cell biology, Venter, cell, genome

Scientists in the US have succeeded in developing the first living cell to be controlled entirely by synthetic DNA. The …
News

Silence Therapeutics promotes Jorg Kaufmann

May 21, 2010 Research and Development Silence Therapeutics, appointment, research and development, rnai

Jorg Kaufmann has been made vice president of research at UK biotech company Silence Therapeutics. He previously served as senior …
Appointment

Antisoma stages comeback with promising cancer drugs

May 20, 2010 Research and Development AML, Antisoma, chemotherapy, leukaemia

UK biotech Antisoma is looking to put previous late-stage trial failures behind it by focusing on two new cancer drugs. …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026